Utilizing the Kaplan–Meier plotter platform, we ascertained that elevated hnRNPA2B1 expression was correlated with diminished overall survival (OS; P = 0.016, Figure 1B) and post‐progression survival (PPS; P = 0.037, Figure 1C), thereby establishing its adverse prognostic significance in patients with GC. This evidence concerns the gene HNRNPA2B1 and gastric cancer.